| 000 | 01631 a2200433 4500 | ||
|---|---|---|---|
| 005 | 20250515030725.0 | ||
| 264 | 0 | _c20061218 | |
| 008 | 200612s 0 0 eng d | ||
| 022 | _a0959-8049 | ||
| 024 | 7 |
_a10.1016/j.ejca.2006.05.002 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aAapro, M S | |
| 245 | 0 | 0 |
_aEORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphomas and solid tumours. _h[electronic resource] |
| 260 |
_bEuropean journal of cancer (Oxford, England : 1990) _cOct 2006 |
||
| 300 |
_a2433-53 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Practice Guideline; Research Support, Non-U.S. Gov't; Review; Systematic Review | ||
| 650 | 0 | 4 |
_aAntineoplastic Agents _xadministration & dosage |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGranulocyte Colony-Stimulating Factor _xtherapeutic use |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aNeoplasms _xdrug therapy |
| 650 | 0 | 4 |
_aNeutropenia _xchemically induced |
| 650 | 0 | 4 | _aRecombinant Proteins |
| 650 | 0 | 4 | _aRisk Factors |
| 700 | 1 | _aCameron, D A | |
| 700 | 1 | _aPettengell, R | |
| 700 | 1 | _aBohlius, J | |
| 700 | 1 | _aCrawford, J | |
| 700 | 1 | _aEllis, M | |
| 700 | 1 | _aKearney, N | |
| 700 | 1 | _aLyman, G H | |
| 700 | 1 | _aTjan-Heijnen, V C | |
| 700 | 1 | _aWalewski, J | |
| 700 | 1 | _aWeber, D C | |
| 700 | 1 | _aZielinski, C | |
| 773 | 0 |
_tEuropean journal of cancer (Oxford, England : 1990) _gvol. 42 _gno. 15 _gp. 2433-53 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.ejca.2006.05.002 _zAvailable from publisher's website |
| 999 |
_c16346885 _d16346885 |
||